GLOW Blend: BPC-157/TB-500/GHK-Cu (70mg vials)
$182.00 – $770.00Price range: $182.00 through $770.00
-
Research blend: GLOW Blend containing BPC-157, TB-500, and GHK-Cu.
-
Per-vial composition: BPC-157 10 mg, TB-500 10 mg, and GHK-Cu 50 mg.
-
Total vial content: 70 mg in a 3 mL vial.
-
Available box combinations: 140 mg, 350 mg, and 700 mg.
-
Purity: 99.88% multi-vial purity.
-
Testing status: Independently tested; purity, endotoxin, and heavy-metals screenings passed.
-
Batch details: Manufacturer ID WF03; batch GW202603.
-
Research focus: Peptide-combination studies, fibroblast and endothelial biology, copper-binding research, cellular signaling, extracellular-matrix pathways, and preclinical laboratory experimentation.
- Independent certificate details, manufacturer IDs, and batch IDs should be reviewed before purchase when available.
- Order cancellations for full refunds are available before shipment; shipped orders cannot be cancelled or refunded.
- For damaged or incorrect goods, photograph the outer packaging, inner packaging, and product labels, then email support within 48 hours of carrier delivery.
Buy GLOW Blend BPC-157/TB-500/GHK-Cu – Peptide Partners
Product Overview & Specifications
GLOW Blend is a combination research-peptide formulation containing BPC-157, TB-500, and GHK-Cu. Peptide Partners supplies this product for in-vitro testing, laboratory experimentation, peptide-interaction studies, cellular signaling research, and preclinical investigation.
Each 70 mg vial contains 10 mg of BPC-157, 10 mg of TB-500, and 50 mg of GHK-Cu. The blend brings together three compounds investigated in separate research areas, including endothelial and fibroblast models, peptide signaling, extracellular-matrix biology, copper-associated chemistry, and oxidative-stress research.
Results from studies of the individual components should not automatically be attributed to the GLOW Blend. The specific combination, component ratio, formulation, stability, and experimental conditions may differ from those used in published studies. Researchers should review the applicable batch documentation and certificate of analysis before beginning any experiment.
Product Specifications
| Specification | Details |
|---|---|
| Product name | GLOW Blend: BPC-157/TB-500/GHK-Cu |
| Product type | Combination research-peptide blend |
| Vial composition | BPC-157 10 mg, TB-500 10 mg, GHK-Cu 50 mg |
| Total vial content | 70 mg |
| Product format | 70 mg vials |
| Vial size | 70 mg |
| Vial capacity | 3 mL |
| Available box combinations | 140 mg, 350 mg, and 700 mg |
| Multi-vial purity | 99.88% |
| Independent testing | Yes |
| Endotoxin screening | Passed |
| Heavy-metals screening | Passed |
| Purity screening | Passed |
| Manufacturer ID | WF03 |
| Batch ID | GW202603 |
| Cost per milligram | $1.10–$1.30 |
The stated 99.88% purity is based on multi-vial testing. Researchers should review the batch-specific certificate of analysis and confirm the identity and relative content of each component before beginning any experiment.
Research Context
BPC-157 Research Context
BPC-157 has been investigated in laboratory and animal research involving endothelial-cell responses, tendon-fibroblast models, vascular signaling, nitric oxide pathways, and cellular migration. These studies evaluate individual experimental mechanisms and should not be treated as direct evidence for the GLOW Blend.
TB-500 Research Context
TB-500 is associated with research into thymosin-beta-4-related peptide biology, including cell migration, actin-associated processes, angiogenesis-related mechanisms, and tissue-model experimentation. Findings involving thymosin beta-4 or related constructs may not apply directly to the specific TB-500 material or the combined GLOW Blend.
GHK-Cu Research Context
GHK-Cu is studied as a copper-binding peptide complex in research involving fibroblast activity, collagen-related pathways, extracellular-matrix markers, oxidative-stress models, copper-associated chemistry, and gene-expression analysis.
Combination-Formulation Considerations
The supplied product data does not identify a published study evaluating this specific BPC-157/TB-500/GHK-Cu formulation. It also does not provide validated compatibility, stability, interaction, or degradation data for the three-component blend.
Researchers evaluating the blend should confirm the identity and relative content of each component, establish suitable analytical controls, and assess the formulation under the intended laboratory conditions. Research findings for BPC-157, TB-500, or GHK-Cu alone should not be presented as findings for the GLOW Blend.
Standard Research Disclaimer
Research Use Only. Not for use in diagnostic tests.
This product is solely intended for research purposes as a chemical compound. It is designated exclusively for in-vitro testing and laboratory experimentation. All information provided about this product is educational and should be evaluated by appropriately qualified research personnel.
By law, bodily introduction of this product into humans or animals is strictly prohibited. This blend must not be used, administered, or represented as a drug, food, dietary supplement, cosmetic, skincare product, wound treatment, diagnostic material, or medical treatment. It is not intended to diagnose, treat, cure, or prevent any disease. It should be handled only by licensed and qualified professionals in an appropriately equipped laboratory and in accordance with applicable laws, institutional procedures, and relevant safety requirements.
| Choose pack |
2 vials × 70mg (140mg total) ,5 vials × 70mg (350mg total) ,10 vials × 70mg (700mg total) |
|---|
- All of our manufacturing partners produce peptides using the Lyophilization (Freeze Drying) process, ensuring products maintain stability for shipping and storage for 12+ months.
- In lyophilized form, they are shelf-stable for many weeks. However, for long-term storage, it is recommended to store them in the freezer.
- We often hear concerns about the standard "discard after 28 days of first use" disclaimer. Don't worry, this has nothing to do with studies regarding the efficacy of specific peptides. 28 days is the FDA requirement for producers of multi-use vials to prove their bacteriostatic maintains efficacy. This minimum requirement becomes the de facto standard.
- In our experience, if you use proper sterile procedures and refrigerated storage, you can continue sampling from the same reconstituted vial for 3+ months.
Certificate records
No published certificate records are available for this product.
Search Certificate Ledger

